Oramed Pharmaceuticals
ORMP
ORMP
116 hedge funds and large institutions have $122M invested in Oramed Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 44 increasing their positions, 15 reducing their positions, and 13 closing their positions.
Holders
116
Holders Change
+23
Holders Change %
+24.73%
% of All Funds
1.79%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
36
Increased
44
Reduced
15
Closed
13
Calls
$5.67M
Puts
$2.52M
Net Calls
+$3.15M
Net Calls Change
-$1.84M
Top Buyers
| 1 |
1
Millennium Management
New York
|
$10.9M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$7.63M |
| 3 |
3
Two Sigma Investments
New York
|
$5.74M |
| 4 |
4
Morgan Stanley
New York
|
$5.52M |
| 5 |
5
Two Sigma Advisers
New York
|
$3.25M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
Koshinski Asset Management
Decatur,
Illinois
| – | -$9.67K | -440 | Closed |
|
|
MAM
127
Meeder Asset Management
Dublin,
Ohio
| – | -$3K | -95 | Closed |
|